MISAA, LLC commenced FDA process for patent pending, tacrolimus enhanced lateral flow assay
/PRNewswire/ -- MISAA and IOS are pleased to announce they have commenced the FDA certification process for the patent pending, tacrolimus immunosuppressant in...